View in EDS PDF Full Text

Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.

Saved in:
Bibliographic Details
Title: Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.
Authors: Tseng WC; Wave Life Sciences, Cambridge, MA, 02138, USA., Reinhart V; Biogen, Cambridge, MA, 02139, USA., Lanz TA; Pfizer, Inc., Cambridge, MA, 02139, USA., Weber ML; Pfizer, Inc., Cambridge, MA, 02139, USA., Pang J; Pfizer, Inc., Cambridge, MA, 02139, USA., Le KXV; Pfizer, Inc., Cambridge, MA, 02139, USA., Bell RD; Pfizer, Inc., Cambridge, MA, 02139, USA., O'Donnell P; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA., Buhl DL; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA. derek.buhl@gmail.com.
Source: Translational psychiatry [Transl Psychiatry] 2021 Feb 19; Vol. 11 (1), pp. 136. Date of Electronic Publication: 2021 Feb 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33608496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tseng+WC%22">Tseng WC</searchLink>; Wave Life Sciences, Cambridge, MA, 02138, USA.<br /><searchLink fieldCode="AU" term="%22Reinhart+V%22">Reinhart V</searchLink>; Biogen, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Lanz+TA%22">Lanz TA</searchLink>; Pfizer, Inc., Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Weber+ML%22">Weber ML</searchLink>; Pfizer, Inc., Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Pang+J%22">Pang J</searchLink>; Pfizer, Inc., Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Le+KXV%22">Le KXV</searchLink>; Pfizer, Inc., Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Bell+RD%22">Bell RD</searchLink>; Pfizer, Inc., Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22O'Donnell+P%22">O'Donnell P</searchLink>; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Buhl+DL%22">Buhl DL</searchLink>; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA. derek.buhl@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101562664%22">Translational psychiatry</searchLink> [Transl Psychiatry] 2021 Feb 19; Vol. 11 (1), pp. 136. <i>Date of Electronic Publication: </i>2021 Feb 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101562664 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2158-3188 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221583188%22">21583188 </searchLink><i>NLM ISO Abbreviation: </i>Transl Psychiatry <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33608496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41398-021-01262-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 136
    Titles:
      – TitleFull: Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tseng WC
      – PersonEntity:
          Name:
            NameFull: Reinhart V
      – PersonEntity:
          Name:
            NameFull: Lanz TA
      – PersonEntity:
          Name:
            NameFull: Weber ML
      – PersonEntity:
          Name:
            NameFull: Pang J
      – PersonEntity:
          Name:
            NameFull: Le KXV
      – PersonEntity:
          Name:
            NameFull: Bell RD
      – PersonEntity:
          Name:
            NameFull: O'Donnell P
      – PersonEntity:
          Name:
            NameFull: Buhl DL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 02
              Text: 2021 Feb 19
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2158-3188
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Translational psychiatry
              Type: main
ResultId 1